0001178913-21-001947.txt : 20210527
0001178913-21-001947.hdr.sgml : 20210527
20210527171833
ACCESSION NUMBER: 0001178913-21-001947
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210521
FILED AS OF DATE: 20210527
DATE AS OF CHANGE: 20210527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weisman Wayne
CENTRAL INDEX KEY: 0001602327
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36612
FILM NUMBER: 21974173
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ReWalk Robotics Ltd.
CENTRAL INDEX KEY: 0001607962
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 HATNUFA ST.
STREET 2: FLOOR 6
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 2069203
BUSINESS PHONE: 97249590123
MAIL ADDRESS:
STREET 1: 3 HATNUFA ST.
STREET 2: FLOOR 6
CITY: YOKNEAM ILIT
STATE: L3
ZIP: 2069203
FORMER COMPANY:
FORMER CONFORMED NAME: Argo Medical Technologies Ltd.
DATE OF NAME CHANGE: 20140513
4/A
1
zk2126123.xml
X0306
4/A
2021-05-21
2021-05-24
0
0001607962
ReWalk Robotics Ltd.
RWLK
0001602327
Weisman Wayne
490 LAPP ROAD
MALVERN
PA
19355
1
0
0
0
Ordinary Shares, par value NIS 0.25 per share
2021-05-21
4
A
0
13888
0.0000
A
90648
I
By Partnership
The Reporting Person is amending the Form 4 filed on May 24, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant.
The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP.
Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company
/s/ Ori Gon as attorney-in-fact
2021-05-27